Review of oral oxymorphone in the management of pain

References

• AdamsMPAhdiehH2004Pharmacokinetics and dose-proportionality of oxymorphone extended release and its metabolites: results of a randomized crossover studyPharmacotherapy244687615098800
   PubMed Web of Science ®Google Scholar
• AdamsMPAhdiehH2005Single- and multiple-dose pharmacokinetic and dose-proportionality study of oxymorphone immediate-release tabletsDrugs R D691915777102
   PubMedGoogle Scholar
• AdamsMPieniaszekJHJrGammaitoniAR2005Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathwaysJ Clin Pharm4533745
   PubMed Web of Science ®Google Scholar
• AhdiehHMaTBabulN2004Efficacy of oxymorphone extended release in postsurgical pain: a randomized clinical trial in knee arthroplastyJ Clin Pharmacol447677615199081
   PubMed Web of Science ®Google Scholar
• ApfelbaumJLChenCMehtaSS2003Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanagedAnesth Analg975344012873949
   PubMed Web of Science ®Google Scholar
• BeaverWTFeiseGA1977A comparison of the analgesic effect of oxymorphone by rectal suppository and intramuscular injection in patients with postoperative painJ Clin Pharmacol172769167128
   PubMed Web of Science ®Google Scholar
• BeaverWTWallensteinSLHoudeRW1977Comparisons of the analgesic effects of oral and intramuscular oxymorphone and of intramuscular oxymorphone and morphine in patients with cancerJ Clin Pharmacol171869866240
   PubMed Web of Science ®Google Scholar
• BelgradeMJSchamberCDLindgrenBR2006The DIRE score: predicting outcomes of opioid prescribing for chronic painJ Pain76718116942953
   PubMed Web of Science ®Google Scholar
• BroomheadAKerrRTesterW1997Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer painJ Pain Symptom Manage1463739262035
   PubMed Web of Science ®Google Scholar
• BrownsteinMJ1993A brief history of opiates, opioid peptides, and opioid receptorsProc Natl Acad Sci USA905391938390660
   PubMed Web of Science ®Google Scholar
• [CDC] Centers for Disease Control and Prevention2002Prevalence of self-reported arthritis or chronic joint symptoms among adults – United States, 2001MMWR Morb Mortal Wkly Rep519485012437034
   PubMedGoogle Scholar
• ChernyNJChangVFragerG1995Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administrationCancer761283938630910
   PubMed Web of Science ®Google Scholar
• DaniellHWLentzRMazerNA2006Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiencyJ Pain72001016516826
   PubMed Web of Science ®Google Scholar
• DhaliwalHSloanPAArkinstallW1995Randomized evaluation of controlled-release codeine and placebo in chronic cancer painJ Pain Symp Manage1061223
   PubMed Web of Science ®Google Scholar
• Endo Pharmaceuticals2007Opana (oxymorphone hydrochloride) tablets [online]Accessed 1 June 2007. URL: http://www.opana.com/pdfs/opana_ir_pi.pdf
   Google Scholar
• ForalPAIneckJRNystromKK2007Oxycodone accumulation in a hemodialysis patientSouth Med J100212417330696
   PubMed Web of Science ®Google Scholar
• FreyeEAnderson-HillemacherARitzdorfI2007Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patientsPain Pract7123917559481
   PubMedGoogle Scholar
• GabrailNYDvergstenCAhdiehH2004Establishing the dosage equivalency of oxymorphone extended-release and oxycodone controlled release in patients with cancer pain: a randomized controlled studyCurr Med Res Opin20911815200750
   PubMed Web of Science ®Google Scholar
• GagnonAMKahanMSrivastavaA2007Opioid use and abuse: is there a problem?Clin J Pain23661217885343
   PubMed Web of Science ®Google Scholar
• GimbelJAhdiehH2004The efficacy and safety of oral immediate-release oxymorphone for postsurgical painAnesth Analg991472715502051
   PubMed Web of Science ®Google Scholar
• GimbelJSWalkerDMaT2005Efficacy and safety of oxymorphone immediate release for the treatment of mild to moderate pain after ambulatory orthopedic surgery: results of a randomized, double-blind, placebo-controlled trialArch Phys Med Rehabil862284916344024
   PubMed Web of Science ®Google Scholar
• HaleMEFleischmannRSalzmanR1999Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic painClin J Pain151798310524470
   PubMed Web of Science ®Google Scholar
• HaleMEAhdiehHMaT2007Efficacy and safety of Opana ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled studyJ Pain81758417145204
   PubMed Web of Science ®Google Scholar
• HaysHHagenNThirlwellM1994Comparative clinical efficacy and safety of immediate and controlled release hydromorphone formulations in severe cancer painCancer741808167521784
   PubMed Web of Science ®Google Scholar
• KalsoEEdwardsJEMooreRA2004Opioids in chronic non-cancer pain: systematic review of efficacy and safetyPain1123728015561393
   PubMed Web of Science ®Google Scholar
• KatzNRauckRAhdiehH2007A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back painCurr Med Res Opin231172817257473
   PubMed Web of Science ®Google Scholar
• KimuraYWalcoGA2007Treatment of chronic pain in pediatric rheumatic diseaseNat Clin Pract Rheumatol3210817396106
   PubMedGoogle Scholar
• KivitzAMaCAhdiehH2006A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or kneeClin Ther283526416750450
   PubMed Web of Science ®Google Scholar
• LeeMALengMEFCooperRM2005Measurements of plasma oxycodone, noroxycodone and oxymorphone levels in a patient with bilateral nephrectomy who is undergoing haemodialysisPalliat Med192596015920941
   PubMed Web of Science ®Google Scholar
• MarkensonJACroftTZhangPG2005Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trialClin J Pain215243516215338
   PubMed Web of Science ®Google Scholar
• MatsumotoAKBabulNAhdiehH2005Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trialPain Med63576616266356
   PubMed Web of Science ®Google Scholar
• McCarbergB2007Tramadol extended-release in the management of chronic painTher Clin Risk Manage3110
   Google Scholar
• McIlwainHAhdiehH2005Safety, tolerability, and effectiveness of oxymorphone extended-release for moderate to severe osteoarthritis pain: a one-year studyAm J Ther121061215767827
   PubMedGoogle Scholar
• MelzackROfieshJGMountBM1976The Brompton mixture: effects on pain in cancer patientsCan Med Assoc J115125958710
   PubMed Web of Science ®Google Scholar
• MercadanteSBrueraE2006Opioid switching: a systematic and critical reviewCancer Treat Rev323041516624490
   PubMed Web of Science ®Google Scholar
• MetzgerTGPaterliniMGFergusonDM2001Investigation of the selectivity of oxymorphone-and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the “address” recognition locusJ Med Chem448576211300867
   PubMed Web of Science ®Google Scholar
• Oxymorphone-Endo/Penwest2003Drugs42046
   Google Scholar
• Penwest Pharmaceuticals Co2007TIMERx technical descriptionAccessed 1 June 2007. URL: http://www.penwest.com/timerx_description.html
   Google Scholar
• PortenoyRK1996Opioid therapy for chronic non-malignant pain: a review of the critical issuesJ Pain Symptom Manage11203178869456
   PubMed Web of Science ®Google Scholar
• PoyhiaRSeppalaT1994Liposolubility and protein binding of oxycodone in vitroPharmacol Toxicol742378159633
   PubMedGoogle Scholar
• RossFBSmithMT1997The intrinsic antinociceptive effects of oxyco-done appear to be kappa-opioid receptor mediatedPain7315179415500
   PubMed Web of Science ®Google Scholar
• SacerdoteP2006Opioids and the immune systemPalliat Med20S91516764216
   PubMed Web of Science ®Google Scholar
• ShueyDLWoodlandCTremblayC2007Oxymorphone hydrochloride, a potent opioid analgesic, is not carcinogenic in rats or miceToxicol Sci961627317138599
   PubMed Web of Science ®Google Scholar
• SinatraR2006Opioid analgesics in primary care: challenges and new advances in the management of noncancer painJ Am Board Fam Med191657716513905
   PubMed Web of Science ®Google Scholar
• SloanPA2007Neuraxial pain relief for intractable cancer painCurr Pain Headache Rep11283917686392
   PubMedGoogle Scholar
• SloanPABabulN2006Extended-release opioids for the management of chronic non-malignant painExp Opin Drug Deliv348997
   PubMedGoogle Scholar
• SloanPAHamannSR2006Ultra low-dose opioid antagonists to enhance opioid analgesiaJ Opioid Manage2295304
   PubMedGoogle Scholar
• SloanPASlatkinNEAhdiehH2005Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: a pilot studySupp Care Cancer135765
   PubMed Web of Science ®Google Scholar
• SloanPAMelzackR1999Long-term patterns of morphine dosage and pain intensity among cancer patientsHosp J14354710624231
   PubMedGoogle Scholar
• StambaughJERederRFStambaughMD2001Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate-release oral oxycodone in cancer pain patientsJ Clin Pharmacol41500611361046
   PubMed Web of Science ®Google Scholar
• SwegleJMLogemannC2006Management of common opioid-induced adverse effectsAm Fam Physician7413475417087429
   PubMed Web of Science ®Google Scholar
• The Medical Letter on Drugs and Therapeutics2007Oral oxymorphone (Opana)The Med Letter4934
   Google Scholar
• ThirlwellMPSloanPAMarounJA1989Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patientsCancer632275832720576
   PubMed Web of Science ®Google Scholar
• WatkinsLRHutchinsonMRLedeboerA2007Glia as the “bad guys”: implications for improving clinical pain control and the clinical utility of opioidsBrain Behav Immun211314617175134
   PubMed Web of Science ®Google Scholar
• Wilder-SmithOHGArendt-NielsenL2006Postoperative hyperalgesiaAnesthesiology104601716508408
   PubMed Web of Science ®Google Scholar
• YelinECallahanLFfor National Arthritis Data Work Groups1995The economic cost and social and psychological impact of musculoskeletal conditionsArthritis Rheum381351627575685
   PubMed Web of Science ®Google Scholar